FVPI — FV Pharma International Income Statement
0.000.00%
Last trade - 00:00
Consumer DefensivesAdventurousMicro Cap
2013 January 31st | 2014 January 31st | |
---|---|---|
Period Length: | 12 M | 12 M |
Source: | PROSPECTUS | 10-K |
Standards: | USG | USG |
Status: | Final | Final |
Revenue | ||
Total Revenue | 0.002 | 0 |
Cost of Revenue | ||
Gross Profit | 0.002 | — |
Selling / General / Administrative Expenses | ||
Other Operating Expenses | ||
Total Operating Expenses | 0.001 | 0.031 |
Operating Profit | 0.002 | -0.031 |
Net Income Before Taxes | 0.002 | -0.031 |
Provision for Income Taxes | ||
Net Income After Taxes | 0.001 | -0.03 |
Net Income Before Extraordinary Items | ||
Net Income | 0.001 | -0.03 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||
Income Available to Common Shareholders Including Extraordinary Items | ||
Dilution Adjustment | ||
Diluted Net Income | 0.001 | -0.03 |
Diluted Weighted Average Shares | ||
Basic EPS Including Extraordinary Items | ||
Diluted EPS Including Extraordinary Items | ||
Diluted EPS Excluding Extraordinary Items | ||
Normalised Income Before Taxes | ||
Normalised Income After Taxes | ||
Normalised Income Available to Common Shareholders | ||
Diluted Normalised EPS | 0.022 | -0.242 |
Dividends per Share |